SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-040578
Filing Date
2020-03-30
Accepted
2020-03-30 17:20:29
Documents
5
Period of Report
2020-03-26
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2014179d1_8k.htm 8-K 33402
2 EXHIBIT 3.1 tm2014179d1_ex3-1.htm EX-3.1 6668
3 EXHIBIT 99.1 tm2014179d1_ex99-1.htm EX-99.1 12806
4 GRAPHIC image_001.jpg GRAPHIC 6644
5 GRAPHIC image_002.jpg GRAPHIC 8322
  Complete submission text file 0001104659-20-040578.txt   75284
Mailing Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292
Business Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37544 | Film No.: 20758421
SIC: 2836 Biological Products, (No Diagnostic Substances)